Furthermore, the apparent up-regulation of α1-AR responsiveness after chronic carvedilol treatment in HF patients [147] and the lack of change after chronic angiotensin-converting enzyme inhibitors [142] might yield important consequences regarding HF therapy. This evidence concerns the gene ACE and hydrops fetalis.